These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4147247)

  • 1. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the effects of propranolol, practolol, oxyprenolol and L.B. 46 on myocardial contractility].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Apr; 26(7):603-8. PubMed ID: 4144788
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of beta-blocking agents.
    Goldstein RE
    Circulation; 1973 Mar; 47(3):443-5. PubMed ID: 4144218
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
    Cheymol G; Mouillé P; Laubie M; Schmitt H
    C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardioselective beta-adrenergic blockade.
    Fitzgerald JD
    Proc R Soc Med; 1972 Sep; 65(9):761-4. PubMed ID: 4404402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 12. The haemodynamic effects of ( )-propranolol, dexpropranolol, oxprenolol, practolol and sotalol in anaesthetised dogs.
    Fitzgerald JD; Wale JL; Austin M
    Eur J Pharmacol; 1972 Jan; 17(1):123-34. PubMed ID: 4401429
    [No Abstract]   [Full Text] [Related]  

  • 13. [What is assured in treatment with beta receptor blockaders?].
    von Egidy H
    Internist (Berl); 1972 Dec; 13(12):481-4. PubMed ID: 4405768
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.
    Ablad B; Carlsson E; Ek L
    Life Sci I; 1973 Feb; 12(3):107-19. PubMed ID: 4144510
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current drugs. Therapy using -blockaders ( -adrenolytics)].
    Gross F
    Internist (Berl); 1973 Mar; 14(3):137-9. PubMed ID: 4144731
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.
    Gibson DG; Hoy J; Sowton E
    Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.